Clinical Study Comparing Single Long BioMimeTM Morph Coronary Stent System vs. Two Overlapping Xience Family Coronary Stent Systems in the Treatment of Patients With Long de Novo Lesions.

NAUnknownINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

September 15, 2019

Primary Completion Date

December 1, 2021

Study Completion Date

June 22, 2022

Conditions
Coronary Artery Disease
Interventions
DEVICE

BioMime™ Morph - Sirolimus Eluting Coronary Stent System

Study Device :- BioMime™ Morph - Sirolimus Eluting Coronary Stent System Approximately 200 patients will be randomly enrolled in a 2:1 ratio \[BioMime™ Morph (n=133) vs. XIENCE family (n=67)\].

DEVICE

Xience family Everolimus Coronary Stent Systems

Active Control Device :- Xience family Everolimus Coronary Stent Systems Approximately 200 patients will be randomly enrolled in a 2:1 ratio \[BioMime™ Morph (n=133) vs. XIENCE family (n=67)\].

Sponsors
All Listed Sponsors
lead

Meril Life Sciences Pvt. Ltd.

INDUSTRY

NCT03721614 - Clinical Study Comparing Single Long BioMimeTM Morph Coronary Stent System vs. Two Overlapping Xience Family Coronary Stent Systems in the Treatment of Patients With Long de Novo Lesions. | Biotech Hunter | Biotech Hunter